OPENING: In an era of media sensationalism, I have come to appreciate good journalism. When it comes to healthcare, my number one choice is STAT News, but I have also found the Financial Times and The Economist to be excellent sources. Below is a summary of an in-depth article from the Finacial Times on Pfizer and their COVID vaccine. It’s beyond damning; it’s a reflection of an industry that values profits above all else.
SUMMARY: According to The Washington Post “President Trump is lashing out at the Food and Drug Administration following a disclosure Monday that an experimental coronavirus vaccine from pharmaceutical giant Pfizer is more than 90 percent effective, convinced the timing — six days after Election Day — proves the “medical deep state” deliberately tried to sabotage his electoral prospects by delaying the results and Azar is agreeing with him. Very sad.
SUMMARY: Pfizer’s 90 percent effectiveness is very impressive, but the rate is based on a relatively small number of people and the data has not been peer-reviewed but today headlines rule the news, not content.
- 41 of Pfizer’s drugs have been picked for a price hike on January 15, averaging 5%.
- Pfizer noted Friday that the increases will be offset by higher rebates and discounts offered to insurance companies and pharmacy benefit managers.
- Pfizer had the highest profit total ($4.1 billion) of any publicly traded health care company in the third quarter.
Pfizer is adding humor to the battle over the post-menopause prescription market. Launched last week the “Let’s talk about change” campaign is a departure from the company’s recent “Tune into Menopause” campaign that featured Kim Cattrall. As someone who has sat in a LOT of research with women this YouTube video really misses the mark.